ADA

New Orleans

Pharma

Eli Lilly is the ‘clear winner’ from ADA, RBC analyst says

Lilly emerged as the “clear winner from ADA,” said RBC's Trung Hyunh, who added “the field is getting more crowded—but Lilly is widening its lead.”

Kevin Dunleavy Jun 8, 2026 3:12pm

Novo Nordisk

Novo's Ozempic 2 mg trumps lower dose on blood sugar reduction

Jun 26, 2021 4:30pm

Trulicity

Lilly's Trulicity tops Ozempic at keeping patients compliant

Jun 14, 2020 2:54pm

sanofi

Sanofi boosts Soliqua with real-world data favoring dual therapy

Jun 13, 2020 11:00am

skyline

Amid pandemic, ASCO moves online while ADA plows ahead

Mar 25, 2020 2:45pm